{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T16:47:29Z","timestamp":1780591649883,"version":"3.54.1"},"reference-count":49,"publisher":"Springer Science and Business Media LLC","issue":"1","license":[{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"},{"start":{"date-parts":[[2025,4,2]],"date-time":"2025-04-02T00:00:00Z","timestamp":1743552000000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/www.springernature.com\/gp\/researchers\/text-and-data-mining"}],"funder":[{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["316404\/2021-7"],"award-info":[{"award-number":["316404\/2021-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100003593","name":"Conselho Nacional de Desenvolvimento Cient\u00edfico e Tecnol\u00f3gico","doi-asserted-by":"publisher","award":["306955\/2023-7"],"award-info":[{"award-number":["306955\/2023-7"]}],"id":[{"id":"10.13039\/501100003593","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002322","name":"Coordena\u00e7\u00e3o de Aperfei\u00e7oamento de Pessoal de N\u00edvel Superior","doi-asserted-by":"publisher","award":["001"],"award-info":[{"award-number":["001"]}],"id":[{"id":"10.13039\/501100002322","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100005667","name":"Funda\u00e7\u00e3o de Amparo \u00e0 Pesquisa e Inova\u00e7\u00e3o do Estado de Santa Catarina","doi-asserted-by":"publisher","award":["CP48\/2021"],"award-info":[{"award-number":["CP48\/2021"]}],"id":[{"id":"10.13039\/501100005667","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Endocrine"],"DOI":"10.1007\/s12020-025-04220-z","type":"journal-article","created":{"date-parts":[[2025,4,4]],"date-time":"2025-04-04T05:23:51Z","timestamp":1743744231000},"page":"79-89","update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Intranasal pramlintide matches intraperitoneal effects on food intake and gastric emptying in mice"],"prefix":"10.1007","volume":"89","author":[{"given":"Milena S.","family":"Almeida","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Mariele P.","family":"Sanches","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Nat\u00e1lia S.","family":"Tonet","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Carine","family":"Zuglianello","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Joseane","family":"Morari","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Licio A.","family":"Velloso","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Elenara","family":"Lemos-Senna","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Alex","family":"Rafacho","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2025,4,2]]},"reference":[{"key":"4220_CR1","unstructured":"International Diabetes Federation: IDF Diabetes Atlas 9th Edition. https:\/\/diabetesatlas.org (2019). Accessed 08 November 2024."},{"key":"4220_CR2","doi-asserted-by":"publisher","first-page":"375","DOI":"10.2165\/0063030-200822060-00004","volume":"22","author":"S Edelman","year":"2008","unstructured":"S Edelman, H Maier, K Wilhelm, Pramlintide in the treatment of diabetes mellitus. BioDrugs 22, 375\u2013386 (2008). https:\/\/doi.org\/10.2165\/0063030-200822060-00004.","journal-title":"BioDrugs"},{"key":"4220_CR3","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/J.APPET.2022.105965","volume":"172","author":"TA Lutz","year":"2022","unstructured":"TA Lutz, Creating the amylin story. Appetite 172, 1\u20139 (2022). https:\/\/doi.org\/10.1016\/J.APPET.2022.105965.","journal-title":"Appetite"},{"issue":"35","key":"4220_CR4","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnmol.2020.00035","volume":"13","author":"AF Raimundo","year":"2020","unstructured":"AF Raimundo, S Ferreira, IC Martins, R Menezes, Islet amyloid polypeptide: A partner in crime with A\u03b2 in the pathology of Alzheimer\u2019s disease. Front. Mol. Neurosci. 13(35), 1\u201314 (2020). https:\/\/doi.org\/10.3389\/fnmol.2020.00035.","journal-title":"Front. Mol. Neurosci."},{"key":"4220_CR5","doi-asserted-by":"publisher","first-page":"564","DOI":"10.1124\/pr.115.010629","volume":"67","author":"DL Hay","year":"2015","unstructured":"DL Hay, S Chen, TA Lutz, DG Parkes, JD Roth, Amylin: Pharmacology, physiology, and clinical potential. Pharmacol. Rev. 67, 564\u2013600 (2015). https:\/\/doi.org\/10.1124\/pr.115.010629.","journal-title":"Pharmacol. Rev."},{"key":"4220_CR6","doi-asserted-by":"publisher","first-page":"1068495","DOI":"10.3389\/fphar.2022.1068495","volume":"13","author":"J Maeng","year":"2022","unstructured":"J Maeng, K Lee, Systemic and brain delivery of antidiabetic peptides through nasal administration using cell-penetrating peptides. Front. Pharmacol. 13, 1068495 (2022). https:\/\/doi.org\/10.3389\/fphar.2022.1068495.","journal-title":"Front. Pharmacol."},{"key":"4220_CR7","doi-asserted-by":"publisher","first-page":"44","DOI":"10.1016\/j.lfs.2017.12.025","volume":"195","author":"TP Crowe","year":"2018","unstructured":"TP Crowe, MHW Greenlee, AG Kanthasamy, WH Hsu, Mechanism of intranasal drug delivery directly to the brain. Life Sci. 195, 44\u201352 (2018). https:\/\/doi.org\/10.1016\/j.lfs.2017.12.025.","journal-title":"Life Sci."},{"key":"4220_CR8","doi-asserted-by":"publisher","first-page":"74","DOI":"10.1016\/j.neuroscience.2019.11.036","volume":"447","author":"B Coester","year":"2020","unstructured":"B Coester, SW Pence, S Arrigoni, CN Boyle, CLe Foll, TA Lutz, RAMP1 and RAMP3 differentially control amylin\u2019s effects on food intake, glucose and energy balance in male and female mice. Neuroscience 447, 74\u201393 (2020). https:\/\/doi.org\/10.1016\/j.neuroscience.2019.11.036.","journal-title":"Neuroscience"},{"issue":"6","key":"4220_CR9","doi-asserted-by":"publisher","first-page":"BSR20194154","DOI":"10.1042\/BSR20194154","volume":"40","author":"X Liu","year":"2020","unstructured":"X Liu, R Yang, W Bai, X Xu, F Bi, Y Hao, Q Yang, H Li, Involvement of amylin B-H2S-connexin 43 signaling pathway in vascular dysfunction and enhanced ischemia-reperfusion-induced myocardial injury in diabetic rats. Biosc. Rep. 40(6), BSR20194154 (2020). https:\/\/doi.org\/10.1042\/BSR20194154.","journal-title":"Biosc. Rep."},{"issue":"6","key":"4220_CR10","doi-asserted-by":"publisher","first-page":"531","DOI":"10.1111\/j.1463-1326.2012.01557.x","volume":"14","author":"J Jelsing","year":"2012","unstructured":"J Jelsing, N Vrang, G Hansen, K Raun, M Tang-Christensen, L Bjerre Knudsen, Liraglutide: short-lived effect on gastric emptying-long lasting effects on body weight. Diabetes, Obes. Metab. 14(6), 531\u2013538 (2012). https:\/\/doi.org\/10.1111\/j.1463-1326.2012.01557.x.","journal-title":"Diabetes, Obes. Metab."},{"issue":"10","key":"4220_CR11","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s12902-020-00678-2","volume":"21","author":"TA Larsen","year":"2021","unstructured":"TA Larsen, S Gydesen, N Sonne, MA Karsdal, K Henriksen, The dual amylin and calcitonin receptor agonist KBP-089 and the GLP-1 receptor agonist liraglutide act complimentarily on body weight reduction and metabolic profile. BMC Endocr. Disord. 21(10), 1\u20139 (2021). https:\/\/doi.org\/10.1186\/s12902-020-00678-2.","journal-title":"BMC Endocr. Disord."},{"issue":"1","key":"4220_CR12","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1038\/s41598-020-60664-5","volume":"10","author":"YM Mousa","year":"2020","unstructured":"YM Mousa, IM Abdallah, M Hwang, DR Martin, A Kaddoumi, Amylin and pramlintide modulate \u03b3-secretase level and APP processing in lipid rafts. Sci. Rep. 10(1), 1\u201314 (2020). https:\/\/doi.org\/10.1038\/s41598-020-60664-5.","journal-title":"Sci. Rep."},{"issue":"4","key":"4220_CR13","doi-asserted-by":"publisher","first-page":"326","DOI":"10.1080\/13813455.2018.1534244","volume":"126","author":"SZ Nassar","year":"2020","unstructured":"SZ Nassar, NM Badae, YA Issa, Effect of amylin on memory and central insulin resistance in a rat model of Alzheimer\u2019s disease. Arch. Physiol. Biochem. 126(4), 326\u2013334 (2020). https:\/\/doi.org\/10.1080\/13813455.2018.1534244.","journal-title":"Arch. Physiol. Biochem."},{"issue":"1020","key":"4220_CR14","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3389\/fnins.2018.01020","volume":"12","author":"FA Gomes","year":"2019","unstructured":"FA Gomes, FA Flores, MA Bruxel, FNda Silva, ELG Moreira, DB Zoccal, RD Prediger, A Rafacho, Glucose homeostasis is not affected in a murine model of Parkinson\u2019s disease induced by 6-OHDA. Front. Neurosc 12(1020), 1\u201318 (2019). https:\/\/doi.org\/10.3389\/fnins.2018.01020.","journal-title":"Front. Neurosc"},{"issue":"4","key":"4220_CR15","doi-asserted-by":"publisher","first-page":"402","DOI":"10.1006\/meth.2001.1262","volume":"25","author":"KJ Livak","year":"2001","unstructured":"KJ Livak, TD Schmittgen, Analysis of relative gene expression data using real-time quantitative PCR and the 2(-Delta Delta C(T)) method. Methods 25(4), 402\u2013408 (2001). https:\/\/doi.org\/10.1006\/meth.2001.1262.","journal-title":"Methods"},{"issue":"2","key":"4220_CR16","doi-asserted-by":"publisher","first-page":"1","DOI":"10.4155\/fdd-2022-0005","volume":"4","author":"C Lamer","year":"2022","unstructured":"C Lamer, Overcoming the shortcomings of peptide-based therapeutics. Future Drug. Discov. 4(2), 1\u201318 (2022). https:\/\/doi.org\/10.4155\/fdd-2022-0005.","journal-title":"Future Drug. Discov."},{"issue":"3","key":"4220_CR17","doi-asserted-by":"publisher","first-page":"180","DOI":"10.18097\/PBMC20196503180","volume":"65","author":"KV Shevchenko","year":"2019","unstructured":"KV Shevchenko, IY Nagaev, LA Andreeva, VP Shevchenko, NF Myasoedov, Stability of proline-containing peptides in biological media. Biomed. Kim. 65(3), 180\u2013201 (2019). https:\/\/doi.org\/10.18097\/PBMC20196503180.","journal-title":"Biomed. Kim."},{"issue":"4","key":"4220_CR18","doi-asserted-by":"publisher","first-page":"780","DOI":"10.1208\/s12248-015-9719-7","volume":"17","author":"ME Meredith","year":"2015","unstructured":"ME Meredith, TS Salameh, WA Banks, Intranasal delivery of proteins and peptides in the treatment of neurodegenerative diseases. AAPS J. 17(4), 780\u2013787 (2015). https:\/\/doi.org\/10.1208\/s12248-015-9719-7.","journal-title":"AAPS J."},{"key":"4220_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.3390\/jcm11082207","volume":"11","author":"CN Boyle","year":"2022","unstructured":"CN Boyle, Y Zheng, TA Lutz, Mediators of amylin action in metabolic control. J. Clin. Med. 11, 1\u201323 (2022). https:\/\/doi.org\/10.3390\/jcm11082207.","journal-title":"J. Clin. Med."},{"issue":"6","key":"4220_CR20","doi-asserted-by":"publisher","first-page":"642","DOI":"10.1007\/BF00401833","volume":"38","author":"AA Young","year":"1995","unstructured":"AA Young, B Gedulin, W Vine, A Percy, TJ Rink, Gastric emptying is accelerated in diabetic BB rats and is slowed by subcutaneous injections of amylin. Diabetologia 38(6), 642\u2013648 (1995). https:\/\/doi.org\/10.1007\/BF00401833.","journal-title":"Diabetologia"},{"issue":"1","key":"4220_CR21","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/s0026-0495(96)90192-4","volume":"45","author":"AA Young","year":"1996","unstructured":"AA Young, BR Gedulin, TJ Rink, Dose-Responses for the slowing of gastric emptying in a rodent model by glucagon-like peptide (7-36)NH2, amylin, cholecystokinin, and other possible regulators of nutrient uptake. Metabolism 45(1), 1\u20133 (1996). https:\/\/doi.org\/10.1016\/s0026-0495(96)90192-4.","journal-title":"Metabolism"},{"key":"4220_CR22","doi-asserted-by":"publisher","first-page":"946","DOI":"10.1152\/ajpgi.2000.278.6.g946","volume":"278","author":"M Samsom","year":"2000","unstructured":"M Samsom, LA Szarka, M Camilleri, A Vella, AR Zinsmeister, RA Rizza, Pramlintide, an amylin analog, selectively delays gastric emptying: Potential role of vagal inhibition. Am. J. Physiol. Gastrointest. Liver Physiol. 278, 946\u2013951 (2000). https:\/\/doi.org\/10.1152\/ajpgi.2000.278.6.g946.","journal-title":"Am. J. Physiol. Gastrointest. Liver Physiol."},{"key":"4220_CR23","doi-asserted-by":"publisher","first-page":"21","DOI":"10.1016\/j.regpep.2008.03.010","volume":"148","author":"J Wickbom","year":"2008","unstructured":"J Wickbom, MK Herrington, J Permet, A Jansson, U Arnelo, Gastric emptying in response to IAPP and CCK in rats with subdiaphragmatic afferent vagotomy. Regul. Pept. 148, 21\u201325 (2008). https:\/\/doi.org\/10.1016\/j.regpep.2008.03.010.","journal-title":"Regul. Pept."},{"issue":"9","key":"4220_CR24","doi-asserted-by":"publisher","first-page":"1497","DOI":"10.1002\/oby.23204","volume":"29","author":"D Gonzalez-Izundegui","year":"2021","unstructured":"D Gonzalez-Izundegui, A Campos, G Calderon, ML Ricardo-Silgado, L Cifuentes, PA Decker, EJ Vargas, L Tran, D Burton, BA Dayyeh, M Camilleri, JE Eckel-Passow, A Acosta, Association of gastric emptying with postprandial appetite and satiety sensations in obesity. Obesity 29(9), 1497\u20131507 (2021). https:\/\/doi.org\/10.1002\/oby.23204.","journal-title":"Obesity"},{"issue":"10","key":"4220_CR25","doi-asserted-by":"publisher","first-page":"1985","DOI":"10.1016\/j.psyneuen.2013.03.003","volume":"38","author":"ID Neumann","year":"2013","unstructured":"ID Neumann, R Maloumby, DI Beiderbeck, M Lukas, R Landgraf, Increased brain and plasma oxytocin after nasal and peripheral administration in rats and mice. Psychoneuroendocrinology 38(10), 1985\u20131993 (2013). https:\/\/doi.org\/10.1016\/j.psyneuen.2013.03.003.","journal-title":"Psychoneuroendocrinology"},{"issue":"3","key":"4220_CR26","doi-asserted-by":"publisher","first-page":"1105","DOI":"10.1021\/acs.molpharmaceut.7b00991","volume":"15","author":"A Tanaka","year":"2018","unstructured":"A Tanaka, T Furubayashi, M Arai, D Inoue, S Kimura, A Kiriyama, K Kusamori, H Katsumi, R Yutani, T Sakane, A Yamamoto, Delivery of oxytocin to the brain for the treatment of autism spectrum disorder by nasal application. Mol. Pharm. 15(3), 1105\u20131111 (2018). https:\/\/doi.org\/10.1021\/acs.molpharmaceut.7b00991.","journal-title":"Mol. Pharm."},{"key":"4220_CR27","doi-asserted-by":"publisher","unstructured":"Wangikar P., Sandhya M.V.S., Choudhari P.: Exploring the Intraperitoneal Route in a New Way for Preclinical Testing. In: R. Shegokar (eds) Exploring Drug Delivery to the Peritoneum. Springer, Cham. (2023) https:\/\/doi.org\/10.1007\/978-3-031-31694-4_10","DOI":"10.1007\/978-3-031-31694-4_10"},{"key":"4220_CR28","doi-asserted-by":"publisher","first-page":"492","DOI":"10.1007\/bf00400683","volume":"39","author":"OG Kolterman","year":"1996","unstructured":"OG Kolterman, S Schwartz, C Corder, B Levy, L Klaff, J Peterson, A Gottlieb, Effect of 14 days\u2019 subcutaneous administration of the human amylin analogue, pramlintide (AC137), on an intravenous insulin challenge and response to a standard liquid meal in patients with IDDM. Diabetologia 39, 492\u2013499 (1996). https:\/\/doi.org\/10.1007\/bf00400683.","journal-title":"Diabetologia"},{"issue":"5","key":"4220_CR29","doi-asserted-by":"publisher","first-page":"805","DOI":"10.2337\/db17-1347","volume":"67","author":"TA Lutz","year":"2018","unstructured":"TA Lutz, B Coester, L Whiting, AA Dunn-Meynell, CN Boyle, SG Bouret, BE Levin, CLe Foll, Amylin selectively signals onto POMC Neurons in the arcuate nucleus of the hypothalamus. Diabetes 67(5), 805\u2013817 (2018). https:\/\/doi.org\/10.2337\/db17-1347.","journal-title":"Diabetes"},{"key":"4220_CR30","doi-asserted-by":"publisher","unstructured":"AS Arora, Anubhuti, Role of neuropeptides in appetite regulation and obesity\u2013a review. Neuropeptides 40(6), 375\u2013401 (2006). https:\/\/doi.org\/10.1016\/j.npep.2006.07.001.","DOI":"10.1016\/j.npep.2006.07.001"},{"key":"4220_CR31","doi-asserted-by":"publisher","first-page":"200","DOI":"10.3389\/fnins.2012.00200","volume":"6","author":"T Liu","year":"2013","unstructured":"T Liu, Q Wang, ED Berglund, Q Tong, Action of neurotransmitter: A key to unlock the AgRP neuron feeding circuit. Front. Neurosci. 6, 200 (2013). https:\/\/doi.org\/10.3389\/fnins.2012.00200.","journal-title":"Front. Neurosci."},{"issue":"2","key":"4220_CR32","doi-asserted-by":"publisher","first-page":"513","DOI":"10.1124\/jpet.107.132381","volume":"325","author":"N Nonaka","year":"2008","unstructured":"N Nonaka, SA Farr, H Kageyama, S Shioda, WA Banks, Delivery of galanin-like peptide to the brain: Targeting with intranasal delivery and cyclodextrins. J. Pharmacol. Exp. Ther. 325(2), 513\u2013519 (2008). https:\/\/doi.org\/10.1124\/jpet.107.132381.","journal-title":"J. Pharmacol. Exp. Ther."},{"issue":"52","key":"4220_CR33","doi-asserted-by":"publisher","first-page":"14239","DOI":"10.1523\/JNEUROSCI.3878-07.2007","volume":"27","author":"SA Deadwyler","year":"2007","unstructured":"SA Deadwyler, L Porrino, JM Siegel, RE Hampson, Systemic and nasal delivery of orexin-A (hypocretin-1) reduces the effects of sleep deprivation on cognitive performance in nonhuman primates. J. Neurosci. 27(52), 14239\u201314247 (2007). https:\/\/doi.org\/10.1523\/JNEUROSCI.3878-07.2007.","journal-title":"J. Neurosci."},{"issue":"5","key":"4220_CR34","doi-asserted-by":"publisher","first-page":"2088","DOI":"10.1210\/en.2005-1016","volume":"147","author":"S Fliedner","year":"2006","unstructured":"S Fliedner, C Schulz, H Lehnert, Brain uptake of intranasally applied radioiodinated leptin in Wistar rats. Endocrinology 147(5), 2088\u20132094 (2006). https:\/\/doi.org\/10.1210\/en.2005-1016.","journal-title":"Endocrinology"},{"key":"4220_CR35","doi-asserted-by":"publisher","first-page":"1833","DOI":"10.1152\/ajpregu.2001.281.6.r1833","volume":"281","author":"T Riediger","year":"2001","unstructured":"T Riediger, HA Schmid, T Lutz, E Simon, Amylin potently activates AP neurons possibly via formation of the excitatory second messenger cGMP. Am. J. Physiol. Reg. Integ. Comp. Physiol. 281, 1833\u20131843 (2001). https:\/\/doi.org\/10.1152\/ajpregu.2001.281.6.r1833.","journal-title":"Am. J. Physiol. Reg. Integ. Comp. Physiol."},{"issue":"7","key":"4220_CR36","doi-asserted-by":"publisher","first-page":"424","DOI":"10.1080\/00498254.2024.2349046","volume":"54","author":"ML Sardu","year":"2024","unstructured":"ML Sardu, I Poggesi, Pharmacokinetics of intranasal drugs, still a missed opportunity?. Xenobiotica 54(7), 424\u2013438 (2024). https:\/\/doi.org\/10.1080\/00498254.2024.2349046.","journal-title":"Xenobiotica"},{"key":"4220_CR37","doi-asserted-by":"publisher","first-page":"366","DOI":"10.1016\/j.jconrel.2024.01.053","volume":"367","author":"D Xu","year":"2024","unstructured":"D Xu, X-J Song, X Chen, J-W Wang, Y-L Cui, Advances and future perspectives of intranasal drug delivery: A scientometric review. J. Control. Rel. 367, 366\u2013384 (2024). https:\/\/doi.org\/10.1016\/j.jconrel.2024.01.053.","journal-title":"J. Control. Rel."},{"issue":"8","key":"4220_CR38","doi-asserted-by":"publisher","first-page":"1562","DOI":"10.3390\/pharmaceutics14081562","volume":"14","author":"A Hafner","year":"2022","unstructured":"A Hafner, Advances in development, characterisation and application of nasal drug delivery systems. Pharmaceutics 14(8), 1562 (2022). https:\/\/doi.org\/10.3390\/pharmaceutics14081562.","journal-title":"Pharmaceutics"},{"key":"4220_CR39","doi-asserted-by":"publisher","first-page":"924","DOI":"10.1152\/ajpendo.00198.2011","volume":"302","author":"T Kusakabe","year":"2012","unstructured":"T Kusakabe, K Ebihara, T Sakai, L Miyamoto, D Aotani, Y Yamamoto, S Yamamoto-Kataoka, M Aizawa-Abe, J Fujikura, K Hosada, K Nakao, Amylin improves the effect of leptin of insulin sensitivity in leptin-resistant diet induced obese mice. Am. J. Physiol. Endocrinol. Metab. 302, 924\u2013931 (2012). https:\/\/doi.org\/10.1152\/ajpendo.00198.2011.","journal-title":"Am. J. Physiol. Endocrinol. Metab."},{"issue":"2","key":"4220_CR40","doi-asserted-by":"publisher","first-page":"850","DOI":"10.1210\/endo.141.2.7378","volume":"141","author":"PA Rushing","year":"2000","unstructured":"PA Rushing, MM Hagan, RJ Seeley, TA Lutz, SC Woods, Amylin: a novel action in the brain to reduce body weight. Endocrinology 141(2), 850\u2013853 (2000). https:\/\/doi.org\/10.1210\/endo.141.2.7378.","journal-title":"Endocrinology"},{"key":"4220_CR41","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1016\/j.physbeh.2020.112958","volume":"222","author":"KA Kern","year":"2020","unstructured":"KA Kern, EG Mietlicki-Baase, Distributed amylin receptor signaling and its influence on motivated behavior. Physiol. Behav. 222, 1\u20138 (2020). https:\/\/doi.org\/10.1016\/j.physbeh.2020.112958.","journal-title":"Physiol. Behav."},{"issue":"1 Pt 2","key":"4220_CR42","doi-asserted-by":"publisher","first-page":"178","DOI":"10.1152\/ajpregu.1994.267.1.r178","volume":"267","author":"JE Morley","year":"1994","unstructured":"JE Morley, JF Flood, M Horowitz, PM Morley, MJ Walter, Modulation of food intake by peripherally administered amylin. Am. J. Physiol. Regul. Integr. Comp. Physiol. 267(1 Pt 2), 178\u2013184 (1994). https:\/\/doi.org\/10.1152\/ajpregu.1994.267.1.r178.","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"issue":"3","key":"4220_CR43","doi-asserted-by":"publisher","first-page":"605","DOI":"10.1152\/ajpregu.2001.280.3.R605","volume":"280","author":"RD Reidelberger","year":"2001","unstructured":"RD Reidelberger, U Arnelo, L Granqvist, J Permet, Comparative effects of amylin and cholecystokinin on food intake and gastric emptying in rats. Am. J. Physiol. Regul. Integr. Comp. Physiol. 280(3), 605\u2013611 (2001). https:\/\/doi.org\/10.1152\/ajpregu.2001.280.3.R605.","journal-title":"Am. J. Physiol. Regul. Integr. Comp. Physiol."},{"key":"4220_CR44","doi-asserted-by":"publisher","first-page":"87","DOI":"10.1016\/j.lfs.2017.12.012","volume":"195","author":"X Xu","year":"2018","unstructured":"X Xu, J Chen, L Hu, M Liang, X Wang, S Feng, J Shen, X Luan, Liraglutide regulates the viability of pancreatic \u03b1-cells and pancreatic \u03b2-cells through cAMP-PKA signal pathway. Life Sci. 195, 87\u201394 (2018). https:\/\/doi.org\/10.1016\/j.lfs.2017.12.012.","journal-title":"Life Sci."},{"issue":"7","key":"4220_CR45","doi-asserted-by":"publisher","first-page":"798","DOI":"10.1177\/0091270007300949","volume":"47","author":"TA Kellmeyer","year":"2007","unstructured":"TA Kellmeyer, NC Kesty, Y Wang, JP Frias, MS Fineman, Pharmacokinetics of an oral drug (Acetaminophen) administered at various times relative to subcutaneous injection of pramlintide in subjects with type 2 diabetes. J. Clin. Pharmacol. 47(7), 798\u2013805 (2007). https:\/\/doi.org\/10.1177\/0091270007300949.","journal-title":"J. Clin. Pharmacol."},{"issue":"9","key":"4220_CR46","first-page":"498","volume":"35","author":"SH Jackson","year":"2010","unstructured":"SH Jackson, TS Martin, JD Jones, D Seal, F Emanuel, Liraglutide (Victoza): The first once-daily incretin mimetic injection for type-2 diabetes. Drug Forecast 35(9), 498\u2013502 (2010).","journal-title":"Drug Forecast"},{"issue":"4","key":"4220_CR47","doi-asserted-by":"publisher","first-page":"46","DOI":"10.22159\/ijap.2024v16i4.50626","volume":"16","author":"C Palde","year":"2024","unstructured":"C Palde, T Barot, G Chakraborthy, L Patel, Peptide delivery via nasal route: exploring recent developments and approaches. Int. J. Appl. Pharm. 16(4), 46\u201356 (2024). https:\/\/doi.org\/10.22159\/ijap.2024v16i4.50626.","journal-title":"Int. J. Appl. Pharm."},{"issue":"3","key":"4220_CR48","doi-asserted-by":"publisher","first-page":"137","DOI":"10.1023\/b:phar.0000026823.82950.ff","volume":"26","author":"S T\u00fcrker","year":"2004","unstructured":"S T\u00fcrker, E Onur, Y Ozer, Nasal route and drug delivery systems. Pharm. World Sci. 26(3), 137\u2013142 (2004). https:\/\/doi.org\/10.1023\/b:phar.0000026823.82950.ff.","journal-title":"Pharm. World Sci."},{"key":"4220_CR49","doi-asserted-by":"publisher","first-page":"136158","DOI":"10.1016\/j.ijbiomac.2024.136158","volume":"281","author":"C Zuglianello","year":"2024","unstructured":"C Zuglianello, AP Fran\u00e7a, BS Souza, JP Agnes, RD Prediger, E Lemos-Senna, Intranasal administration of dextran-pramlintide polyelectrolyte complex-coated nanoemulsions improves cognitive impairments in a mouse model of Alzheimer\u2019s disease. Int. J. Biol. Macromol. 281, 136158 (2024). https:\/\/doi.org\/10.1016\/j.ijbiomac.2024.136158.","journal-title":"Int. J. Biol. Macromol."}],"container-title":["Endocrine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04220-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/article\/10.1007\/s12020-025-04220-z\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/link.springer.com\/content\/pdf\/10.1007\/s12020-025-04220-z.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2025,7,4]],"date-time":"2025-07-04T06:49:23Z","timestamp":1751611763000},"score":1,"resource":{"primary":{"URL":"https:\/\/link.springer.com\/10.1007\/s12020-025-04220-z"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,4,2]]},"references-count":49,"journal-issue":{"issue":"1","published-online":{"date-parts":[[2025,7]]}},"alternative-id":["4220"],"URL":"https:\/\/doi.org\/10.1007\/s12020-025-04220-z","relation":{},"ISSN":["1559-0100"],"issn-type":[{"value":"1559-0100","type":"electronic"}],"subject":[],"published":{"date-parts":[[2025,4,2]]},"assertion":[{"value":"11 November 2024","order":1,"name":"received","label":"Received","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"20 March 2025","order":2,"name":"accepted","label":"Accepted","group":{"name":"ArticleHistory","label":"Article History"}},{"value":"2 April 2025","order":3,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with ethical standards"}},{"value":"The authors declare no competing interests.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of interest"}}]}}